Cargando…

Association of COVID-19 Vaccination and Clinical Severity of Patients Infected with Delta or Omicron Variants — China, May 21, 2021–February 28, 2022

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Compared with the international mRNA and adenovirus-vectored coronavirus disease 2019 (COVID-19) vaccines, there is less real-world research data about breakthrough cases in people vaccinated with China-made COVID-19 vaccines. Analyses of clinical outcomes of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Mingshuang, Liu, Qianqian, Wu, Dan, Tang, Lin, Wang, Xiaoqi, Yan, Tingting, An, Zhijie, Yin, Zundong, Gao, Geroge F., Wang, Fuzhen, Zheng, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022
Materias:	Preplanned Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008265/ https://www.ncbi.nlm.nih.gov/pubmed/35433093 http://dx.doi.org/10.46234/ccdcw2022.074

Ejemplares similares

Effectiveness of Inactivated COVID-19 Vaccines Against Symptomatic, Pneumonia, and Severe Disease Caused by the Delta Variant: Real World Study and Evidence — China, 2021
por: Wu, Dan, et al.
Publicado: (2022)

Comparison of Omicron and Delta Variant Infection COVID-19 Cases — Guangdong Province, China, 2022
por: Hu, Ting, et al.
Publicado: (2022)

Timing and Magnitude of the Second Wave of the COVID-19 Omicron Variant — 189 Countries and Territories, November 2021 to February 2023
por: Niu, Beidi, et al.
Publicado: (2023)

Effectiveness of COVID-19 Vaccination Against SARS-CoV-2 Omicron Variant Infection and Symptoms — China, December 2022–February 2023
por: Fu, Di, et al.
Publicado: (2023)

COVID-19 Vaccination Rates of People Who Use Drugs — Chengdu City, Sichuan Province, China, November 2021 – February 2022
por: Du, Erri, et al.
Publicado: (2022)

Effectiveness of DTaP Against Pertussis in ≤2-Year-Old Children — Linyi Prefecture, Shandong Province, China, 2017–2019
por: Zhu, Pinpin, et al.
Publicado: (2023)

Survey on Immunization Services for Children with Medical Conditions — China, 2022
por: Huang, Yong, et al.
Publicado: (2023)

Oral Sexual Behavior Among HIV-Infected Men Who Have Sex with Men — China, February 2021
por: Fu, Leiwen, et al.
Publicado: (2022)

Epidemic Features of COVID-19 and Potential Impact of Hospital Strain During the Omicron Wave — Australia, 2022
por: Yang, Jingli, et al.
Publicado: (2023)

COVID-19 Stay-At-Home Orders and Older Adults’ Cognitive Health — United States, June 2018–February 2022
por: Choi, Nam Sun, et al.
Publicado: (2022)

The Associated Factors of SARS-CoV-2 Reinfection by Omicron Variant — Guangdong Province, China, December 2022 to January 2023
por: Cai, Chunsheng, et al.
Publicado: (2023)

The Infection of Healthcare Workers and the Reinfection of Patients by Omicron Variant — Jiangsu Province, China, December 2022 to January 2023
por: Zhang, Chuanmeng, et al.
Publicado: (2023)

A Cross-Sectional Survey of Iodized Salt Usage in Dining Establishments — 13 PLADs, China, 2021–2022
por: Zhang, Ying, et al.
Publicado: (2023)

Transmission Dynamics and Epidemiological Characteristics of the SARS-CoV-2 Delta Variant ― Hunan Province, China, 2021
por: Luo, Kaiwei, et al.
Publicado: (2023)

Comparative Analysis of Vaccine Inequity and COVID-19 Transmission Amid the Omicron Variant Among Countries — Six Countries, Asia-Pacific Region, 2022
por: Yang, Jingli, et al.
Publicado: (2023)

Molecular Identification and Genetic Characterization of Public Health Threatening Ticks — Chongming Island, China, 2021–2022
por: Fei, Siwei, et al.
Publicado: (2023)

COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022
por: Smith, Dallas J., et al.
Publicado: (2022)

Chinese American Caregivers’ Attitudes Toward Tube Feeding for Persons with Dementia — USA, 2021–2022
por: Pei, Yaolin, et al.
Publicado: (2022)

Impact of Influenza and Pneumococcal Polysaccharide Vaccination on Economic Burden from Acute Exacerbations of Chronic Obstructive Pulmonary Disease — Hebei Province, China, November 2018 to November 2020
por: Li, Yan, et al.
Publicado: (2023)

Diagnostic Value of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Patients with Severe COVID-19 — 7 PLADs, China, January 21–February 10, 2020
por: Ma, Yan, et al.
Publicado: (2022)

Risk Factors Associated with the Spatiotemporal Spread of the SARS-CoV-2 Omicron BA.2 Variant — Shanghai Municipality, China, 2022
por: Zheng, Wen, et al.
Publicado: (2023)

Identification of Novel Bartonella washoensis Sequence Type 22 in Marmota himalayana — Jiuquan City, Gansu Province, China, 2021–2022
por: Duan, Ran, et al.
Publicado: (2023)

A Comparison of Clinical Characteristics of Infections with SARS-CoV-2 Omicron Subvariants BF.7.14 and BA.5.2.48 — China, October–December 2022
por: Huo, Da, et al.
Publicado: (2023)

Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 – February 2022)
por: Petrone, Daniele, et al.
Publicado: (2023)

Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients with Chronic Obstructive Pulmonary Disease — Hebei Province, China, September−December, 2019
por: Li, Yan, et al.
Publicado: (2021)

Preliminary Study of the Protectiveness of Vaccination Against the COVID-19 in the Outbreak of VOC Omicron BA.2 — Jilin City, Jilin Province, China, March 3–April 12, 2022
por: Fan, Xuebin, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Variant is Expected to Retain Most of the Spike Protein Specific Dominant T-Cell Epitopes Presented by COVID-19 Vaccines — Worldwide, 2021
por: Jiang, Jiajing, et al.
Publicado: (2022)

City-Specific Effects of Lifting Mobility Restrictions — China, February–March 2020
por: Han, Shasha, et al.
Publicado: (2022)

Willingness of the General Public to Receive A COVID-19 Vaccine Booster — China, April–May 2021
por: Wang, Xiaoxiao, et al.
Publicado: (2022)

Spatiotemporal analysis of the morbidity of global Omicron from November 2021 to February 2022
por: Liang, Yuelang, et al.
Publicado: (2022)

Predicting the Incident Cases of Emerging Infectious Disease Using a Bayesian Probability Model — China, February 2020
por: Zhang, Yewu, et al.
Publicado: (2020)

Cross-Sectional Online Survey on Depression and Anxiety Among the Population Infected or Non-Infected with COVID-19 — China, December 2022
por: Qin, Tingting, et al.
Publicado: (2023)

Association Between COVID-19 Vaccination Coverage and Case Fatality Ratio: a Comparative Study — Hong Kong SAR, China and Singapore, December 2021–March 2022
por: He, Guanhao, et al.
Publicado: (2022)

Mushroom Poisoning Outbreaks — China, 2022
por: Li, Haijiao, et al.
Publicado: (2023)

Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older: A Dosing Interval Study — Yunnan Province, China, 2021–2022
por: Yang, Haitao, et al.
Publicado: (2023)

Mushroom Poisoning Outbreaks — China, 2021
por: Li, Haijiao, et al.
Publicado: (2022)

Modeling the Prediction on the Efficacy of a Homologous Third Dose of CoronaVac Against SARS-CoV-2 Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 — China, 2020–2021
por: Chen, Xinhua, et al.
Publicado: (2023)

Impact of Whole Lung Lavage on Pneumoconiosis Patients — China, 2018–2022
por: Chen, Yun, et al.
Publicado: (2023)

Prevalence and Types of Comorbidities in Pneumoconiosis — China, 2018–2021
por: Wang, Huanqiang, et al.
Publicado: (2023)

A Questionnaire Survey on Extrapulmonary Tuberculosis Control and Prevention — China, 2021
por: Wang, Mingzhe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0j7td7kci950dt3ook73smci6k